Log In or Register to view a pdf version

For multiple reprints Click Here

Healthpoint Initiates Study to Evaluate Cell Based Therapy’s Effectiveness

     Healthpoint (Fort Worth, Tex) recently announced that it has initiated a Phase II clinical trial investigating the efficacy of HP802-247 in venous leg ulcers. HP802-247 is a topical spray containing living keratinocytes and fibroblasts. The study is designed to determine the effectiveness of two cell concentrations and two dosing frequencies of HP802-247 when combined with standard care compared to placebo plus standard care in healing venous leg ulcers over a 12-week treatment period.

     The study is a randomized, double blind, dose-finding study that consists of subjects 18 years and older with venous leg ulcers of at least 6 weeks, but not more than 24 months’ duration. Approximately 400 subjects will be recruited at 25 investigational centers in the United States. The study will assess both the time to complete wound closure and the proportion of complete wound closures in each cohort. Commencement of enrollment for this trial represents an important milestone in the development program for this novel biologic therapy. This second Phase II study will extend the understanding of the spray, which will add to the promising results obtained in pervious European clinical trials.

     Visit www.healthpoint.com for more information.

NACCME Signs 5-Year Agreements with the WHS and the AAWC

     North American Center for Continuing Medical Education LLC ([NACCME] Millstone Township, NJ), a leading accredited medical education and communications company, which sponsors the Symposium on Advanced Wound Care and Wound Healing Society (SAWC/WHS) Spring conference and the soon-to-launch SAWC Fall program, announced today it has signed new 5-year agreements with the WHS and the Association for the Advancement of Wound Care (AAWC). The WHS agreement continues the partnership and co-location with the annual SAWC/WHS Spring meeting through 2013. The partnership with the AAWC also includes SAWC/WHS Spring and extends it to include the upcoming SAWC Fall meeting, launching in September 2009 in Washington, DC.

     For more than 2 decades, the SAWC and WHS have hosted thousands of physicians, podiatrists, nurses, physical therapists, researchers, dieticians, and medical professionals involved in wound care and wound healing to discuss the scientific breakthroughs, advances, and treatments in the field. In addition to its involvement with SAWC/WHS Spring and SAWC Fall, NACCME also sponsors CME/CE activities that reach medical professionals—physicians, pharmacists, podiatrists, nurses, physician assistants, and other allied healthcare professionals—in many different formats.

     CME/CE activities sponsored by NACCME are produced to strengthen practitioner awareness of evidence-based patient care advances in a broad range of therapeutic areas, illustrating NACCME’s commitment to improving healthcare practitioner knowledge, competence, and performance, ultimately to improve patient care.

     Call 609-371-1137 for more information.